Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biological Products	1.98B	1.87B	2.10B	1.56B	1.30B
Biological Products Growth	6.14%	-11.16%	34.93%	20.15%	44.65%
Chinese Patent Medicine	289.17M	298.97M	358.25M	404.44M	518.74M
Chinese Patent Medicine Growth	-3.28%	-16.55%	-11.42%	-22.03%	13.69%
Synthetic drugs	150.25M	151.13M	178.58M	147.47M	134.65M
Synthetic drugs Growth	-0.58%	-15.37%	21.09%	9.53%	6.65%
Active Pharmaceutical Ingredient (API)	101.58M	103.24M	91.77M	72.35M	62.56M
Active Pharmaceutical Ingredient (API) Growth	-1.60%	12.49%	26.86%	15.64%	5.58%
Technical Services	24.73M	31.62M	58.34M	76.39M	94.64M
Technical Services Growth	-21.79%	-45.80%	-23.63%	-19.28%	-19.66%
Others	100.88M	85.69M	79.04M	74.22M	54.53M
Others Growth	17.73%	8.42%	6.49%	36.12%	40.63%
Total	2.65B	2.54B	2.87B	2.33B	2.16B
Total Growth	4.36%	-11.51%	22.94%	7.91%	27.54%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
East China (Excluding Anhui)	975.33M	963.21M	1.06B	824.92M	-
East China (Excluding Anhui) Growth	1.26%	-9.31%	28.75%	-	-
Anhui	237.49M	175.22M	227.33M	207.09M	-
Anhui Growth	35.54%	-22.92%	9.77%	-	-
Central and Southwest China	652.18M	612.50M	700.27M	553.68M	-
Central and Southwest China Growth	6.48%	-12.53%	26.48%	-	-
North China, Northeast Region	325.16M	310.58M	335.55M	317.83M	-
North China, Northeast Region Growth	4.69%	-7.44%	5.58%	-	-
South China	337.40M	347.55M	417.69M	349.93M	-
South China Growth	-2.92%	-16.79%	19.36%	-	-
Northwest China	115.25M	122.68M	115.23M	69.33M	-
Northwest China Growth	-6.05%	6.46%	66.21%	-	-
Unallocated	3.19M	2.65M	4.57M	4.18M	-
Unallocated Growth	20.55%	-42.09%	9.36%	-	-
Overseas	513.03K	1.66M	2.98M	4.10M	4.44M
Overseas Growth	-69.09%	-44.36%	-27.28%	-7.53%	-9.65%
Mainland China	-	-	-	-	2.16B
Mainland China Growth	-	-	-	-	27.65%
Total	2.65B	2.54B	2.87B	2.33B	2.16B
Total Growth	4.36%	-11.51%	22.94%	7.91%	27.54%

Source: S&P Global Market Intelligence.